Chief Medical Officer 2022
DOI: 10.33920/med-03-2207-15
|View full text |Cite
|
Sign up to set email alerts
|

Use of rebamipide gastroprotector agent in clinical practice

Abstract: Recent studies have indicated that rebamipide is a drug with a pleiotropic effect, covering the upper and lower gastrointestinal tract and also extending beyond it. Rebamipide has prospects for use in endocrinology (in the model of diabetes mellitus, the drug showed hypoglycemic and antioxidant functions, which helped alleviate the symptoms of diabetic nephropathy); an anti-atherosclerotic effect of rebamipide has been shown; in rheumatology, its ability to reduce inflammation in the joints has been revealed; … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 6 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?